Capital Insight Partners LLC Decreases Holdings in Intuitive Surgical, Inc. $ISRG

Key Points

• Capital Insight Partners LLC decreased its stake in Intuitive Surgical, Inc. by 4.8%, owning 17,136 shares valued at approximately $9.31 million.
• Intuitive Surgical reported a 21.4% increase in revenue year-over-year, with earnings per share of $2.19 for the last quarter, surpassing analysts' expectations.
• Institutional investors control 83.64% of Intuitive Surgical's stock, indicating significant interest from large investors, with several companies increasing their holdings in the first quarter.

Capital Insight Partners LLC trimmed its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 4.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 17,136 shares of the medical equipment provider's stock after selling 856 shares during the quarter. Intuitive Surgical makes up 1.6% of Capital Insight Partners LLC's holdings, making the stock its 16th biggest position. Capital Insight Partners LLC's holdings in Intuitive Surgical were worth $9,312,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of the stock. Nuveen LLC purchased a new stake in Intuitive Surgical in the first quarter worth $1,715,899,000. Goldman Sachs Group Inc. grew its stake in shares of Intuitive Surgical by 26.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider's stock worth $1,396,496,000 after acquiring an additional 584,375 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Intuitive Surgical by 20.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider's stock worth $1,680,922,000 after acquiring an additional 566,979 shares during the last quarter. Wellington Management Group LLP raised its stake in Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider's stock valued at $1,732,975,000 after acquiring an additional 457,080 shares during the period. Finally, Vanguard Group Inc. lifted its holdings in Intuitive Surgical by 1.4% during the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider's stock valued at $16,178,258,000 after purchasing an additional 453,335 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Price Performance

ISRG opened at $441.12 on Monday. The company has a fifty day moving average price of $469.43 and a 200-day moving average price of $501.66. The firm has a market capitalization of $158.13 billion, a P/E ratio of 61.52, a price-to-earnings-growth ratio of 4.62 and a beta of 1.61. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm's revenue was up 21.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.78 earnings per share. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the sale, the insider directly owned 19,827 shares of the company's stock, valued at $9,368,059.23. This represents a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the stock. Wells Fargo & Company lifted their target price on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a research note on Wednesday, July 23rd. BTIG Research lifted their price objective on shares of Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research note on Wednesday, July 23rd. Erste Group Bank reissued a "hold" rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Piper Sandler reaffirmed an "overweight" rating and issued a $595.00 price target (up from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, Wall Street Zen cut Intuitive Surgical from a "buy" rating to a "hold" rating in a research report on Friday. Thirteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $595.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.